posted
ENCY Approved in Europe waiting for approval in US. in at 4.33 and 6.11. Anyone else have new news.... Hoping to see it go up soon
Encysive gets formal EC approval for Thelin Marketwatch - August 11, 2006 1:23 PM ET
Related Quotes Symbol Last Chg ENCY Trade 4.41 +0.07 Quotes delayed at least 15 minutes
SAN FRANCISCO (MarketWatch) -- Encysive Pharmaceuticals Inc. said Friday it has received the formal decision letter from the European Commission granting marketing authorization for Thelin 100 mg tablets. Thelin is indicated for the treatment of patients with pulmonary arterial hypertension, which afflicts around 100,000 to 200,000 people in North America and Europe, Houston-based Encysive said.
Posts: 63 | From: Frisco, TX | Registered: Aug 2006
| IP: Logged |
quote:Originally posted by Angie Ramirez: ENCY Approved in Europe waiting for approval in US. in at 4.33 and 6.11. Anyone else have new news.... Hoping to see it go up soon
Encysive gets formal EC approval for Thelin Marketwatch - August 11, 2006 1:23 PM ET
Related Quotes Symbol Last Chg ENCY Trade 4.41 +0.07 Quotes delayed at least 15 minutes
SAN FRANCISCO (MarketWatch) -- Encysive Pharmaceuticals Inc. said Friday it has received the formal decision letter from the European Commission granting marketing authorization for Thelin 100 mg tablets. Thelin is indicated for the treatment of patients with pulmonary arterial hypertension, which afflicts around 100,000 to 200,000 people in North America and Europe, Houston-based Encysive said.
The chart is VERY SCARY. I can't predict this one at all. It has soooooo many jumps in price. You might see it move up $0.25 or so but then I would say it will JUMP and who knows which way. I'm staying far away from this one. Too bad it doesn't have a predictable pattern because it is very EXPLOSIVE.
Posts: 2367 | From: Detroit | Registered: Mar 2005
| IP: Logged |
posted
Well the chart may look scary, but if the FDA approves the drug I am sure it will go up- hoping for at least 10-12
Posts: 63 | From: Frisco, TX | Registered: Aug 2006
| IP: Logged |
posted
well Im fairly new to this, but BE looks to have HUGE resistance at $8.40, it tested it again on friday and closed slightly down. I'm going to keep my eye on it, and would personally buy once it breaks resistance, or gets down to about $7.7 where it has nice support.
posted
OldBlue: I'm not fully understanding the chart your using. I would really appreciate it if you could explain how it works a little. Thanks
Posts: 671 | Registered: Nov 2005
| IP: Logged |
posted
Thanks for the heads up on gnta Im going to watch that. Might be great play by the end of the week.
Posts: 671 | Registered: Nov 2005
| IP: Logged |
posted
What I will be watching tomorrow for a good entry point will first be CORT and second will be KIRK.
For Cort I'm looking for it to open and stay above 1.19 as that is the pivot point. On Kirk I doubt it will run tomorrow I think its a day or two out but I'm going to watch both and see. GLTA!!!
Posts: 671 | Registered: Nov 2005
| IP: Logged |
posted
Mystic, another one that might be a decent buy is AID (Amex). I bought this in August and its made a few nice returns since. I wish the volume was higher but I'll take green any way I can.
Law Enforcement Associates Corporation (LEA) (Amex: AID), a leading provider of surveillance and security products to the global law enforcement, military, security and corrections markets, today announced it has received a $638,000 order for its wireless video kits. The order represents a 25% increase in the value of an existing contract with an agency of the U.S. Government.
The order, which is expected to ship in next year's first quarter, brings the total value of the contract to $2.9 million. In July, the same agency placed a $532,000 order for similar kits, and announced it had extended its contract with LEA through May of 2007. The agency originated the contracted in May 2005 and has executed the first of two possible extensions to the term of the agreement.
Paul Feldman, LEA's president, said, "We have taken more than $1 million in orders during the past two months from this single agency. Our wireless video kits are clearly addressing important surveillance issues for this customer, and the level of follow-on business we are receiving is very encouraging."
Terms of the contract do not allow LEA to identify its customer or the anticipated use of its products.
Feldman added, "We are working aggressively to market these and other devices in our product portfolio, and will be attending a major industry trade show later in the month as part of our effort to build broader exposure for our surveillance and security solutions."
About Law Enforcement Associates, Inc. (LEA)
LEA is a leading security and surveillance technology company that manufactures and markets a diverse product line to the worldwide law enforcement, military, security and corrections markets. The company's Audio Intelligence Devices (AID) division has been serving the law enforcement sector for more than 30 years and is one of the most respected names in the surveillance equipment industry. LEA's products are used by a wide variety of government and non-governmental agencies, as well as public and private companies. These include military bases, nuclear facilities, embassies, government installations, oil refineries, United Nations and NATO locations. LEA's products also have been used at high-profile events such as the Summer & Winter Olympics, Super Bowl, U.S. Golf Championship, and the Democratic and Republican National Conventions. Its products include the Under Vehicle Inspection System (UVIS), EDK123 (Explosive Detection Kit), Bloodhound GPS Tracking System, Letter-bomb Visualizer Spray, and a wide variety of Audio & Video Surveillance Equipment. Headquartered in Youngsville, N.C., the company has been featured in many industry publications and websites. For more information, please visit www.leacorp.com.
Forward-Looking Information:
The statements in this news release contain forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve certain risks, assumptions and uncertainties, including the inability to generate and secure the necessary product sales, or the lack of acceptance of the company's products by its customers. In each case actual results may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or modified) will not be realized.
CONTACT: Pfeiffer High Investor Relations, Inc. Geoff High 303-393-7044
SOURCE Law Enforcement Associates Corporation
Geoff High, of Pfeiffer High Investor Relations, Inc., +1-303-393-7044
posted
PETS......Not sure if I would touch this one. It has a mild pattern with the 2 year chart but fell off the boat. I believe it will drop back down to $10 even.
BKHM....if it follows the pattern it should drop down some more then gradually move back up. It would be a true swing trade.
AID....not a lot of volume....looks like a dead beat to me.
CORT.......I like this pick! I would think it will follow "ELTK" pattern when their stock dropped out of the blue. This should be good for $0.25-0.60 bounce within 3 weeks or so.
KIRK.....has a pattern. It should move back up slowly in Sept. and a quick pop in Octover before falling hard again. Should be good for $0.75 gain.
GNTA....WOW.....hard hit!!! I'm going to buy some today for a quick bounce. I think its a great opportunity to make a few quick bucks.
Well, I will be more active this week...I'm refusing all the OT this week.
Wednesday will be exciting!!
Posts: 2367 | From: Detroit | Registered: Mar 2005
| IP: Logged |
BERKELEY HEIGHTS, N.J., Sept 06, 2006 /PRNewswire-FirstCall via COMTEX/ -- Genta Incorporated (GNTA) announced today that a majority of members on the Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted not to recommend approval of Genasense(R) (oblimersen sodium) Injection for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). While the committee's recommendation is not binding, the FDA will consider this opinion during completion of its ongoing review of the Genasense New Drug Application (NDA), which is targeted for October 29, 2006.
"While we are disappointed with today's outcome, we strongly believe in the potential of Genasense and what it may offer patients with advanced cancer," said Dr. Raymond P. Warrell Jr., Genta's Chief Executive Officer. "We remain committed to the development of this agent and will continue working with FDA regarding their review of this application."
This stock was halted which should of saved it from $0.40. I believe it will still crash maybe down to $0.55-.60 Thursday when trading resumes. I am jumping in when it does because it SHOULD move back up to $0.80-1.00 within a few months.
Posts: 2367 | From: Detroit | Registered: Mar 2005
| IP: Logged |
posted
I tried to buy CORT and ML said that the symbol couldn't be found.....WTH??? Anyways, Good luck to you all. I sold my EGI today and bought some more CMGI.
Posts: 2367 | From: Detroit | Registered: Mar 2005
| IP: Logged |
Topic Closed
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Frown]](frown.gif)
